Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | CCR1 | P32246 | 2/20 | 0.43 |
| ▸ | CCR8 | P51685 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28462134 | 0.89 | LMNA (0.54) | LMNAMAPTKDM4ECYP3A4HTT | |
| SCHEMBL10923942 | 0.82 | LMNA (0.53) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL310511 | 0.81 | LMNA (0.67) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL6513577 | 0.80 | LMNA (1.00) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL8313 | 0.80 | LMNA (1.00) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL7040605 | 0.80 | LMNA (0.65) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL28126432 | 0.80 | LMNA (0.65) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL18743109 | 0.80 | LMNA (0.55) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL28007256 | 0.80 | LMNA (0.65) | LMNAMAPTKDM4ECYP3A4HSP90AA1 | |
| SCHEMBL9860875 | 0.79 | LMNA (0.69) | LMNAMAPTKDM4ECYP3A4HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994027436-A1 | PRESERVATIVE SYSTEMS WITH ENHANCED ANTIMICROBIAL ACTIVITY | DECICCO BENEDICT T (US) | 1994-12-08 | — | — | WO | claimed |
| CN-111848663-B | Non-metal organic complex salt of phenanthroline and phenanthroline derivative, and preparation method and application thereof | 西南大学 | 2022-06-10 | — | — | CN | disclosed |
| CN-111848663-A | Non-metal organic complex salt of phenanthroline and phenanthroline derivative, and preparation method and application thereof | 西南大学 | 2020-10-30 | — | — | CN | disclosed |
| US-8956738-B2 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-20130180590-A1 | PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM SOLAR CELL COMPRISING SAID COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2013-07-18 | — | — | US | disclosed |
| EP-2599780-A1 | PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM PHOTOVOLTAIC CELL COMPRISING SAID COMPOUND | Idemitsu Kosan Co., Ltd. (JP) | 2013-06-05 | — | — | EP | disclosed |
| EP-2373650-B1 | TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER | NOSCIRA SA (ES) | 2012-10-24 | — | — | EP | disclosed |
| US-8257981-B2 | Lanthanide chelates and use thereof in bioanalysis | SENSIENT IMAGING TECHNOLOGIES GMBH (DE) | 2012-09-04 | — | — | US | disclosed |
| EP-2485892-A1 | ORGANIC ELEMENT FOR LOW VOLTAGE ELECTROLUMINESCENT DEVICES | Global OLED Technology LLC (US) | 2012-08-15 | — | — | EP | disclosed |
| US-20110306631-A1 | TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER | NOSCIRA, S.A. (ES) | 2011-12-15 | — | — | US | disclosed |
| EP-2373650-A1 | TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER | Noscira, S.A. (ES) | 2011-10-12 | — | — | EP | disclosed |
| US-20110136242-A1 | Lanthanide Chelates and Use Thereof in Bioanalysis | SENSIENT IMAGING TECHNOLOGIES GMBH (DE) | 2011-06-09 | — | — | US | disclosed |
| WO-2011044009-A1 | ORGANIC ELEMENT FOR LOW VOLTAGE ELECTROLUMINESCENT DEVICES | GLOBAL OLED TECHNOLOGY LLC (US) | 2011-04-14 | — | — | WO | disclosed |
| WO-2010066832-A1 | TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER | NOSCIRA, S.A. (ES) | 2010-06-17 | — | — | WO | disclosed |
| EP-2196466-A1 | Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or heamatological diseases or conditions | NOSCIRA, S.A. (ES) | 2010-06-16 | — | — | EP | disclosed |
| US-20100019671-A1 | ORGANIC ELEMENT FOR LOW VOLTAGE ELECTROLUMINESCENT DEVICES | EASTMAN KODAK COMPANY | 2010-01-28 | — | — | US | disclosed |
| CN-1668616-A | Charge transport compositions comprising fluorizated quinazoline derivatives | DU PONT (US) | 2005-09-14 | — | — | CN | disclosed |
| WO-1994027436-A1 | PRESERVATIVE SYSTEMS WITH ENHANCED ANTIMICROBIAL ACTIVITY | DECICCO BENEDICT T (US) | 1994-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306631-A1 | TRIPLE SUBSTITUTED PHENANTHROLINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE OR HAEMATOLOGICAL DISEASES OR CONDITIONS, OR CANCER | HTT, PFN1, PSEN1 | LMNA 1060/4885MAPT 12/4885KDM4E 1171/4885 |
| US-20110136242-A1 | Lanthanide Chelates and Use Thereof in Bioanalysis | LANCL2, LANCL1, SSB | LMNA 2348/4885MAPT 4811/4885KDM4E 2885/4885 |
| US-20130180590-A1 | PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM SOLAR CELL COMPRISING SAID COMPOUND | SLC43A1, SLC7A5, SLC9A2 | LMNA 1378/4885MAPT 2918/4885KDM4E 1109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.